Engineering immunogenic consensus T helper epitopes for a cross-clade HIV vaccine. (Q51581860)

7 April 2018

title

Engineering immunogenic consensus T helper epitopes for a cross-clade HIV vaccine. (English)

1 reference

7 April 2018

author

Anne Searls De Groot

1

1 reference

7 April 2018

Michelle Lally

4

1 reference

7 April 2018

Kenneth Mayer

7

object named as

Kenneth H Mayer

1 reference

7 April 2018

William D Martin

9

object named as

William Martin

1 reference

7 April 2018

Luisa Marcon

5

object named as

Luisa Marcon

1 reference

7 April 2018

author name string

Elizabeth A Bishop

2

1 reference

7 April 2018

Basim Khan

3

1 reference

7 April 2018

Judith Franco

6

1 reference

7 April 2018

Charles C J Carpenter

8

1 reference

7 April 2018

publication date

1 December 2004

1 reference

7 April 2018

published in

Methods

1 reference

7 April 2018

volume

34

1 reference

7 April 2018

issue

4

1 reference

7 April 2018

page(s)

476-487

1 reference

7 April 2018

Clinical trials of HIV vaccines.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

7 January 2021

The HIV-1 vaccine race

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

HIV vaccine fails in phase 3 trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

Public health. AIDS vaccine trial produces disappointment and confusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

Mixed results win HIV vaccine a guarded response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

Strategies for an HIV vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

Escape of human immunodeficiency virus from immune control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

CD8 T cell anti-HIV activity as a complementary protective mechanism in vaccinated chimpanzees.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

Immune control of HIV-1 after early treatment of acute infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

From genome to vaccine: in silico predictions, ex vivo verification.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

Immuno-informatics: Mining genomes for vaccine components

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

Mapping cross-clade HIV-1 vaccine epitopes using a bioinformatics approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

Viral escape from dominant simian immunodeficiency virus epitope-specific cytotoxic T lymphocytes in DNA-vaccinated rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

Prediction of well-conserved HIV-1 ligands using a matrix-based algorithm, EpiMatrix.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

Exact prediction of a natural T cell epitope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

The discovery of MHC restriction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

HLA supertypes and supermotifs: a functional perspective on HLA polymorphism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

Human immunodeficiency virus reverse transcriptase T helper epitopes identified in mice and humans: correlation with a cytotoxic T cell epitope.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

Bioinformatics tools for identifying class I-restricted epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

Three regions of HIV-1 gp160 contain clusters of immunodominant CTL epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

Immune defence against HIV-1 infection in HIV-1-exposed seronegative persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

Induction of cytotoxic T-cell responses by gene gun DNA vaccination with minigenes encoding influenza A virus HA and NP CTL-epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

Synergistic effect of immunization with a peptide cocktail inducing antibody, helper and cytotoxic T-cell responses on protection against respiratory syncytial virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

Generation and maintenance of memory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

Memory T cells and vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

The majority of immunogenic epitopes generate CD4+ T cells that are dependent on MHC class II-bound peptide-flanking residues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

Defined flanking spacers and enhanced proteolysis is essential for eradication of established tumors by an epitope string DNA vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

Proliferative responses to human immunodeficiency virus type 1 (HIV-1) gp120 peptides in HIV-1-infected individuals immunized with HIV-1 rgp120 or rgp160 compared with nonimmunized and uninfected controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

An HLA-directed molecular and bioinformatics approach identifies new HLA-A11 HIV-1 subtype E cytotoxic T lymphocyte epitopes in HIV-1-infected Thais.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

7 January 2021

Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

7 January 2021

An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

7 January 2021

Maintaining the integrity of human immunodeficiency virus sequence databases.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

7 January 2021

A multivalent minigene vaccine, containing B-cell, cytotoxic T-lymphocyte, and Th epitopes from several microbes, induces appropriate responses in vivo and confers protection against more than one pathogen

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.003

7 January 2021

10.1016/J.YMETH.2004.06.003

Identifiers

DOI

1 reference

7 April 2018

PubMed ID

15542374

1 reference

7 April 2018